MDSSMerck Digital Science
Studio
← All companies
Cohort 2022

Stem Pharm

Providing physiologically relevant in vitro human models of complex neurologic diseases to pharma companies for use in drug discovery and preclinical development.

Part of the Studio communityCohort 2022
Connect with MDSS

Your next step starts
with a conversation.

Building a company, exploring the program or looking to contribute? Tell us what you have in mind.

Let’s talk Founders · Partners · Mentors